| |
| |
|
| Insider
Information: |
Bennett C Frank |
| Relationship: |
Officer Level 14 |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
79,462 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,985,387 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
79,462 |
|
|
| Total
Value |
$2,985,387 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
7
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -99.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ionis Pharmaceuticals Inc |
IONS |
Officer Level 14 |
2024-02-29 |
79,462 |
2003-07-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
191 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IONS |
Ionis Pharmaceuticals Inc |
Senior Vice President |
• – – |
2009-04-07 |
4 |
OE |
$6.81 |
$68,100 |
D/D |
10,000 |
10,687 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Senior Vice President |
• – – |
2009-04-22 |
4 |
OE |
$6.81 |
$68,100 |
D/D |
10,000 |
10,687 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2012-07-09 |
4 |
OE |
$6.81 |
$71,670 |
D/D |
10,500 |
6,277 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2015-11-06 |
4 |
OE |
$14.47 |
$72,350 |
D/D |
5,000 |
12,316 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2015-11-10 |
4 |
OE |
$14.47 |
$72,350 |
D/D |
5,000 |
12,316 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Vice President |
• – – |
2006-05-05 |
4 |
AS |
$8.50 |
$72,740 |
D/D |
(8,500) |
339 |
|
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chief Scientific Officer |
• – – |
2023-02-06 |
4 |
S |
$40.57 |
$73,560 |
D/D |
(1,813) |
69,651 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
Senior Vice President |
• – – |
2010-12-27 |
4 |
OE |
$9.63 |
$74,113 |
D/D |
7,700 |
8,261 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Senior Vice President |
• – – |
2011-08-04 |
4 |
AS |
$7.62 |
$76,206 |
D/D |
(10,000) |
305 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2014-08-27 |
4 |
OE |
$15.38 |
$76,900 |
D/D |
5,000 |
6,627 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2012-07-03 |
4 |
AS |
$12.91 |
$77,460 |
D/D |
(6,000) |
1,277 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Senior Vice President |
• – – |
2010-12-27 |
4 |
AS |
$10.42 |
$80,234 |
D/D |
(7,700) |
561 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Senior Vice President |
• – – |
2009-07-23 |
4 |
OE |
$6.81 |
$81,720 |
D/D |
12,000 |
12,976 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2015-03-23 |
4 |
OE |
$14.47 |
$86,820 |
D/D |
6,000 |
8,229 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2016-01-19 |
4 |
S |
$41.46 |
$87,474 |
D/D |
(2,110) |
10,590 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2018-02-01 |
4/A |
OE |
$7.25 |
$90,625 |
D/D |
12,500 |
31,614 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2018-05-11 |
4 |
OE |
$7.25 |
$90,625 |
D/D |
12,500 |
31,614 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chief Scientific Officer |
• – – |
2024-02-02 |
4 |
S |
$49.52 |
$91,752 |
D/D |
(1,853) |
79,079 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
Vice President |
• – – |
2006-11-09 |
4 |
AS |
$10.13 |
$101,300 |
D/D |
(10,000) |
831 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2017-07-24 |
4 |
OE |
$10.29 |
$102,900 |
D/D |
10,000 |
25,041 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2015-01-16 |
4 |
S |
$67.96 |
$103,169 |
D/D |
(1,518) |
7,229 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Senior Vice President |
• – – |
2008-08-20 |
4 |
AS |
$17.97 |
$107,820 |
D/D |
(6,000) |
537 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2017-01-17 |
4 |
S |
$46.29 |
$112,069 |
D/D |
(2,421) |
14,788 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Vice President |
• – – |
2007-08-21 |
4 |
AS |
$12.50 |
$125,000 |
D/D |
(10,000) |
197 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2017-10-18 |
4 |
OE |
$10.29 |
$126,053 |
D/D |
12,250 |
27,291 |
0 |
- |
|
191 Records found
|
|
Page 5 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
